TA118 Colorectal cancer (metastatic) - bevacizumab & cetuximab: Guidance
|
TA118 Colorectal cancer (metastatic) - bevacizumab & cetuximab: Guidance
24 January 2007 (282.91 Kb 1 mins 22 sec) |
